Expansion opportunities NMT serves 54 hospitals across the Mid-Atlantic with on-site EEG and intraoperative neuromonitoring, and is expanding telemedicine to ICU neuromonitoring nationwide. This presents a sales opportunity to partner with additional hospitals within their current network and to upsell telemedicine ICU neuromonitoring services to new regions.

Clinical staffing With over 30 clinical neurophysiologists and five board-certified neurologists performing more than six thousand IONM procedures annually, there is potential to offer extended monitoring reach, contract-based staffing for high-demand periods, or credentialing and training programs to hospitals seeking to build in-house capabilities.

ICU and EMU focus Strong emphasis on continuous EEG monitoring for neurosurgical, pediatric, neonatal, surgical, and general medicine ICUs and EMUs suggests cross-sell opportunities to hospitals expanding ICUs or enhancing ICU neuromonitoring programs, particularly in pediatric and neonatal settings.

Telemedicine leverage NMT’s telemedicine capability enables rapid brain function assessment across ICUs nationwide, indicating a scalable product channel for selling remote neuromonitoring services to hospitals outside the Mid-Atlantic and to international partners as they explore global opportunities.

Private label and partnerships As a privately held provider with a robust service footprint and a growing suite of on-site EEG and IONM offerings, there is a pathway to explore private-label monitoring solutions, contract-based partner programs, or co-managed services with health systems seeking to expand neuromonitoring without large capital investments.